M&A Deal Summary

ReAble Therapeutics Acquires Empi

On August 8, 2004, ReAble Therapeutics acquired medical products company Empi from The Carlyle Group for 360M USD

Acquisition Highlights
  • This is ReAble Therapeutics’ 1st transaction in the Medical Products sector.
  • This is ReAble Therapeutics’ largest (disclosed) transaction.
  • This is ReAble Therapeutics’ 1st transaction in the United States.
  • This is ReAble Therapeutics’ 1st transaction in Minnesota.

M&A Deal Summary

Date 2004-08-08
Target Empi
Sector Medical Products
Buyer(s) ReAble Therapeutics
Sellers(s) The Carlyle Group
Deal Type Add-on Acquisition
Deal Value 360M USD
Advisor(s) J.P. Morgan Securities (Financial)

Target

Empi

St. Paul, Minnesota, United States
Empi was a medical device companies for rehabilitative medicine in the U.S.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ReAble Therapeutics

Austin, Texas, United States

Category Company
Founded 1992
Sector Medical Products
DESCRIPTION

ReAble Therapeutics, Inc. is a diversified rehabilitation and orthopedic devices company that develops, manufactures and distributes a comprehensive range of electrotherapy, traction, chiropractic and iontophoresis devices, in addition to a broad line of orthopedic implants, used by orthopedic surgeons, physicians, therapists and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events and sports-related injuries.


DEAL STATS #
Overall 1 of 3
Sector (Medical Products) 1 of 3
Type (Add-on Acquisition) 1 of 3
State (Minnesota) 1 of 2
Country (United States) 1 of 2
Year (2004) 1 of 1
Size (of disclosed) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-11-14 Compex Technologies

New Brighton, Minnesota, United States

Compex Technologies, Inc. engages in designing and manufacturing transcutaneous electrical nerve stimulation and electrical muscle stimulation (EMS) products used for pain management, rehabilitation, fitness and sports performance enhancement in clinical, home healthcare, sports and occupational medicine settings.

Buy $109M

Seller(S) 1

SELLER

The Carlyle Group

Washington, District of Columbia, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1987
PE ASSETS 435.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
Carlyle's corporate headquarters on Pennsylvania Ave. in Washington, DC.
Carlyle's corporate headquarters on Pennsylvania Ave. in Washington, DC.

The Carlyle Group is a global investment firm that pursues private equity, credit, and real estate investments worldwide. Carlyle's private equity practice practice pursues buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. With offices in 19 countries, Carlyle can easily target opportunities throughout North America, Europe, Asia, Australia, the Middle East/North Africa and Latin America. Broad sectors of interest include aerospace, defense, automotive and transportation, consumer, retail, energy and power, financial services, healthcare, industrial, infrastructure, technology services, business services, telecommunications and media. The Carlyle Group was formed in 1987 and is based in Washington DC.


DEAL STATS #
Overall 39 of 480
Sector (Medical Products) 2 of 10
Type (Add-on Acquisition) 19 of 197
State (Minnesota) 1 of 2
Country (United States) 31 of 259
Year (2004) 15 of 24
Size (of disclosed) 67 of 135
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-08-01 P&I

Wiesbaden, Germany

P&I is an internationally operating, full suite provider of cloud-based HR software solutions and a driver of innovation in HR technology. P&I’s scalable subscription-based platform exhibits characteristics that resonate with Hg Saturn’s core focus, with a broad, diversified and loyal customer base, and has delivered an exceptional historical operating performance. P&I was founded in 1968 and is based in Wiesbaden, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2004-09-01 Cellutions

Duluth, Georgia, United States

Cellutions, Inc. was formed to commercialize a novel device-based treatment for the cosmetic appearance of cellulite.

Buy -